These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19133920)

  • 1. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
    Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
    Grob JJ; Lachapelle JM
    Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A; Pichler WJ
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
    Augustin M; Ehrle S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L
    Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
    Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
    Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desloratadine for chronic idiopathic urticaria].
    Rottem M; Elbirt D; Sthoeger Z;
    Harefuah; 2005 Aug; 144(8):547-53, 599, 598. PubMed ID: 16146151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
    Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
    Lennox RD; Leahy MJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A; Neukirch C; Dreyfus I; Devillier P
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Ring J; Hein R; Gauger A; Bronsky E; Miller B
    Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.